Reporter April 22 2022

Calculating risk for uterine fibroids

Vanderbilt researchers have constructed a polygenic risk score for uterine fibroids that will be useful for exploring causes of these benign tumors and identifying novel drug targets and therapies.

Molecular testing across tumor types

The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

Shumway Lecture

Ashish Shah, MD, chair of Cardiac Surgery, Carmen Solórzano, MD, chair of Surgery, and Seth Karp, MD, chair of the Section of Surgical Sciences and director of the Vanderbilt Transplant Center, welcome Sara Shumway, MD, (second from left), prior to her delivering the 2022 Shumway Lecture in Transplantation at Vanderbilt.

Vanderbilt University School of Medicine student Meredith Huszagh works with study participant Brij Desai in a diabetes prevention program at the Shade Tree Clinic.

Diabetes prevention program run by students shows success

Seventy-five percent of participants in a diabetes prevention program run by medical students lost at least 5% of their body weight, and many participants also reported less pain and an overall improved quality of life.

VUMC faculty members attending the meeting of the American Society for Clinical Investigation included, from left, Wesley Ely, MD, MPH, Patrick Hu, MD, PhD, Lorraine Ware, MD, Kimryn Rathmell, MD, PhD, Consuelo Wilkins, MD, MSCI, Christopher Williams, MD, PhD, Lori Jordan, MD, PhD, Natasha Halasa, MD, MPH, ASCI Council Member Julie Bastarache, MD, Eric Tkaczyk, MD, PhD, and James Crowe Jr., MD.

VUMC a national leader in physician-scientist training

Physician-scientists from Vanderbilt University Medical Center were well represented at the recent annual meeting of the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP) and the American Physician-Scientist Association.

Study casts doubt on impact of menthol-flavored tobacco ban

Vanderbilt research finds that a ban on the sale of menthol-flavored cigarettes that the U.S. Food and Drug Administration (FDA) is on track to implement may have unintended consequences.

1 2